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Abstract 
Carbene and Diradical-Generating  
Cyclizations of Dialkynyl Azoles 
Ashley Lauren Jewett, M.S.P.S 
The University of Texas at Austin, 2019 
Supervisor: Christian P. Whitman 
Study of the aza-Bergman rearrangement was expanded to include thermolysis of 
the 1,2-dialkynylpyrrole (1,2-DAP) and a 1,5-dialkynylpyrazole (1,5-DAPz). The product 
obtained from thermolysis of 1,2-DAP was a six-membered pyridine-containing species, 
resulting from the rearrangement of the starting 1,2-DAP to a cumulene intermediate and 
then finally to a carbene-containing species. After performing kinetics experiments of the 
thermolysis with the 1,2-DAP, the resulting experimental  calculations were found to be 
within good agreement of theoretical calculations for the aza-Bergman rearrangement. 
Thermolysis of a 1,5-DAPz, however, resulted in a variety of different products. The 
mechanism of formation behind these products have not been confirmed, but several 
possibilities are put forth. 
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CHAPTER 1:  BACKGROUND ON THE BERGMAN CYCLIZATION 
The Bergman cyclization (BC) is an event in which an enediyne undergoes the 
breaking of two 𝜋-bonds with the formation of a new σ-bond (Figure 1.1) upon exposure 
to an activating trigger. The thermally induced rearrangement 
was originally reported in 1972 by Robert Bergman, who 
observed that the thermal cyclization of enediyne (Figure 1.2, 
2a) in the presence of deuterated solvent resulted in the 
rearrangement to 2b.1 The absence of mixed products led to 
the conclusion that the “scrambling” event was a 
unimolecular phenomenon. The p-benzyne diradical intermediate was identified upon 
observing the formation of distinct radical reaction products when performing the BC in 
various solvents. One example of such experiments was the formation of 
phenylmethanol, as opposed to the ionic reaction product anisole, when thermolyzing 
enediyne in methanol (Figure 1.3).2  
 The BC allowed for new synthetic routes to be 
available for chemists when designing new projects 
and creating polycyclic molecules.3 Despite its 
obvious synthetic uti l i ty, interest in the 
rearrangement did not peak until the discovery of 
naturally-occurring enediyne antibiotics, whose 
potency was found to be attributable to a key BC 
event.4 This link to biological activity led to an 
increase in demand for scientists to continue 
learning more about the physical chemistry of the 
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Figure 1.1: Bergman 
cyclization
Figure 1.2: BC and deuterated 
enediynes
phenomenon. In doing so, researchers hoped to gain more control over a potentially 
powerful therapeutic tool.  
 Cyclization 
The Bergman cyclization can be characterized by a break in two proximally located π 
bonds with a formation of one σ bond. Thus, 
the remaining two electrons left over as a 
result of this cyclization makes for a 
diradicaloid intermediate (Figure 1.1, 1a).5 
The stability of the diradicaloid intermediate 
is largely achieved from the molecule's 
newfound aromaticity.6  
It should be noted that the term “diradicaloid,” rather than “diradical,” is used to 
describe the BC intermediate. The “diradicaloid” term still refers to a molecule that 
contains two electrons in nonbonding molecular orbitals (NBMOs); however, these 
NBMOs are not energetically degenerate7 due to through-[𝜎]bond8 and through-space9 
coupling effects. This energy discrepancy between the two NBMOs directly dictates the 
distinction of a diradicaloid from a diradical, and it also, unsurprisingly, has further 
implications towards the ground electronic multiplicity state for each species. 
 Singlet versus triplet state 
For diradicals and diradicaloids, the spin of the two electrons may be either paired 
(singlet state) or unpaired (triplet state).10  For diradicals and their degenerate NBMOs, 
the triplet state is the electronic ground state due to electron repulsion forces, in 
accordance with Hund’s rule. In 1981, however, Bergman found that the radical reaction 
performing, reactive intermediate was present in a singlet electronic state.11  
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Figure 1.3: BC in MeOH
For diradicaloids, the difference in energy between the two MOs means that the 
ground state for the two non-bonding electrons is a closed-shell singlet, based on the 
aufbau principle. The energetic gap between the highest occupied MO (HOMO) and 
lowest unoccupied MO (LUMO) is significant enough to where the amount of 
stabilization that is provided by intramolecular coupling will “outweigh” any energetic 
penalty resulting from same-charge, repulsive forces.7  In order to perform any radical 
reactions, an electronic decoupling of the two nonbonding electrons is required.  
 The S-T gap 
The extent of the energetic “hurdle” at which one electron will need to overcome in order 
to achieve the uncoupled, singly-occupied MOs is analogous to the radical reactivity of 
that diradicaloid intermediate. A commonly used method to quantify this value is to 
determine the difference in energy between the open-shell singlet and triplet excited 
states,12 known as the S-T gap (Figure 1.4). The smaller the gap, the more reactive the 
intermediate and the higher the likelihood that a radical reaction will occur.13 A large 
energy difference between the HOMO and the LUMO will result in the uncoupling event 
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Figure 1.4: Free energy comparison of zwitterion 
versus singlet and triplet states5
occurring less readily, which will increase the likelihood the closed-shell singlet will 
proceed via an ionic mechanism.14  
 It stands to reason that manipulating the energy gap between the highest occupied 
and lowest unoccupied NBMOs through energetically stabilizing or destabilizing factors 
will enable direct control over radical reactivity of the intermediate. The major factors 
that influence whether the diradicaloid proceeds through a radical versus ionic reaction 
are solvent polarity and the molecule’s electronegativity.5 However, the amount of BC 
ionic events that have been reported is remarkably far less compared to that reported for 
radical events. This observation is most likely due to the fact that the radical reaction 
performing intermediate has significant therapeutic applicability.  
 Significance in therapeutics 
Some naturally-occurring antibiotics contain an enediyne moiety (Figure 1.5).15,16 These 
antibiotics were classed together based on their ability to damage DNA via the formation 
of a reactive diradical intermediate through BC.4   
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Figure 1.5: Enediyne-containing antibiotics15,16
The cytotoxicity of these antibiotics arise from radical-induced H-atom 
abstraction off of the DNA sugar-phosphate backbone, an event which leads to breakage 
of the double-stranded DNA,4b ultimately causing cell death. This same reactivity and 
biological mechanism of action are the reasons behind the interest in applying the BC in 
anticancer tools and why enediyne antibiotics have appeared in clinical trials in the past.17 
One of the problems faced in getting enediynes to work effectively in anticancer therapy 
is the high amount of toxicity they present towards healthy cells. 
The designs of mimics and new enediynes try to modulate the reactivity of the BC 
intermediate. The hope is to strike the best balance between potency and cancer cell 
selectivity. Researchers have focused on several different methods of control in trying to 
improve an enediyne’s therapeutic specifications while maintaining its ability to 
successfully cleave DNA, including selective photoactivation,18 variable temperature19 
and pH dependence,20 metal ligand chelation,21 and ene-core modification.  
 Variations and the aza-Bergman rearrangement 
BC research has expanded to start include new systems, which vary from the classic 
enediyne archetype, in order to adjust control of the formed intermediate’s reactivity. One 
way found to be effective in stabilizing the singlet state, thereby increasing the S-T gap, 
was through modification of the ene-core through incorporation of a nitrogen atom, 
forming a C,N-dialkynylimine (Figure 1.6, 3a).22  
 When heated, 3a was found to undergo rearrangement; however, the obtained 
product (3b) differed from the expected diradical trapped product (3c). Rather, the singlet 
state of the diradicaloid intermediate persisted due to stabilization from zwitterionic 
resonance,5 facilitating a ring opening retro-aza-Bergman event to form 3b. In other 
words, the stabilization that is provided by the lone pair of electrons on the nitrogen 
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allows for a low enough barrier in forming the stable 3b aryne23 that the uncoupling of 
the diradicaloid is no longer an energetically favorable route.  
In terms of biological use, however, these dialkynylimines were found to be highly 
susceptible to hydrolysis,24 thus limiting their potential therapeutic applicability. This 
susceptibility lead to further exploration of aza-Bergman cyclization (aza-BC) events 
with enediynes where the nitrogen atom of the ene-core is “tied-up” within ring 
structures.25,26  
 The 1,2-Dialkynylimidazole 
The study of aza-BC expanded to include the heterocyclic aza-enediyne: 1,2-
dialkynylimidazole (1,2-DAI) (Figure 1.7, 4a).26 
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Figure 1.6: The aza-Bergman rearrangement. A free energy comparison shows the 
uncoupling of the diradicaloid to perform diradical H-atom abstraction is unfavorable 
compared to the retro-aza-BC ring opening.
When the thermolyses of 1,2-DAIs were performed in non-halogenated aromatic 
or aliphatic solvents, the results were similar to those seen from previous aza-enediyne 
experiments in that no trapped diradical products were observed, and a retro-aza-
Bergman rearrangement still occurred. However, due to the heterocyclic-bound ene-core, 
a cumulene (4b) was proposed to form from the rearrangement instead of an aryne. 
Subsequently, the collapse of the cumulene intermediate resulted in a pyrazine-containing 
carbene species (4c).27 
Notable solvent effects were observed when performing the BC of the 1,2-DAI in 
halogenated solvents. A significant amount of the rearranged product showed retention of 
the imidazole structure (Scheme 1.8, 5a).28 It has not yet been determined whether the 
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Scheme 1.8: Thermolysis of 1,2-DAI in halogenated solvent28
formation of 5a is the result of a chloride trapping the zwitterion or of a chloride 
nucleophilic  attack,29 similar to what lead to the chlorovinyl imidazole product, and 
subsequent cyclization (Figure 1.9).30 
The occurrence of this intramolecular rearrangement is a competitive event to 
intermolecular radical reaction pathways when undergoing the aza-BC. The balance for 
these aza-enediynes, for the most part, have weighed in favor of intramolecular 
rearrangement. In further exploring the series of heterocyclic enediyne systems and their 
respective abilities to undergo an aza-BC, the next step was to look at the pyrrole diyne. 
The pyrrole diyne was the focus of my research and is presented in the following chapter.  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Figure 1.9: Possibilities for observed product (A) Aza-BC induced formation and trapping 
of zwitterion (B) Induced cyclization following nucleophilic attack
CHAPTER 2: THE 1,2-DIALKYNYLPYRROLE  
Preliminary DFT calculations (Figure 2.1) at the (U)B3LYP/6-31G** level31 
indicated that the next logical N-heterocyclic diyne to study in the aza-BC series was the 
1,2-dialkynylpyrrole (1,2-DAP). This rationale is based on the 1,2-DAP having the 
second lowest activation energy, after 1,2-DAI, in forming the diradicaloid species.  
 Synthesis 
The synthesis of the starting 1,2-dialkynylpyrrole (1,2-DAP) was met with some 
difficulty at the start (Scheme 2.2). The unstable 2-bromo pyrrole 6a was formed from 
the pyrrole using N-Bromosuccinimde (NBS). The remaining crude material was 
suspended in hexanes, which allowed for the insoluble succinimide to be filtered out. 
This solution was used directly in the subsequent Sonogashira reaction with trimethylsilyl 
(TMS) acetylene, since attempts to evaporate down the hexanes would quickly result in 
!  9
Figure 2.1: ΔE for various N-heterocyclic diynes undergoing aza-BC.31 A) Graphical 
representation of DFT calculations showing intermediates formed during aza- BC.  B) 
Legend containing numerical values from DFT calculations of aza-BC for each 
heterocycle.
1,2-DAP
B)A)
decomposition of 6a, a finding consistent with literature reports.32 An initial thin-layer 
chromatography (TLC) of the products of the Sonogashira reaction indicated the 
formation of multiple species which, upon purification and evaporation, were found to be 
unstable. Additionally, all attempts to selectively halogenate the 2-position of pyrrole-
TIPS acetylene 6b failed. The formation of a 1:1 solution of 2-mono and 2,5-dibromo 
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Scheme 2.2: Attempted synthetic routes towards pyrrole diyne
species was obtained, yet attempts to purify proved to be unsuccessful. In pushing the 
bromination to the 2,5-dibromo species, a subsequent Sonogashira failed in forming 
anything in notable amounts. Additionally, the formylation of 6b yielded a mix of 
formylated product at the 2- (6c) and 3- positions.  
 The most productive and successful selective functionalization at the 2- position 
was done by first performing the Vilsmeier-Haak formylation on pyrrole33 and then by 
performing an N-alkynylation34 on the resulting pyrrole-2-carboxaldehyde (Scheme 2.3). 
Homologation was performed using a modified Ohira-Bestmann reagent35 (7a) and 
provided modest yields of diyne 7b. Final deprotection afforded the desired 1,2-DAP 
product, the starting material for the thermolyses experiments.  
A new obstacle materialized when deprotecting the triisopropylsilyl (TIPS) group 
and isolating the target 1,2-DAP. The desired molecule is relatively volatile, and it should 
be noted that it can cause headaches when handled outside the fume hood. Even when 
performing TLC, the small amount of 1,2-DAP contained within the spotter was enough 
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Scheme 2.3: Final synthetic route for 1,2-DAP and subsequent aza-BC product.
to induce a headache. Therefore, it was important that upon purification of the 
deprotected diyne, the procedure does not involve any evaporative step. Towards this end, 
since THF is used as solvent when deprotecting, it was also employed as the solvent for 
the kinetics experiments. In order to purify out the 1,2-DAP after deprotection, without 
losing an excessive amount of material, the reaction solution in THF underwent column 
chromatography, without evaporating off the THF solvent and using THF as the mobile 
phase.  
 Kinetics 
The kinetics for the formation of the carbene were determined by the disappearance of 
starting material against a standard. The assumption that the loss of starting material can 
be directly associated with the formation of the carbene insertion product 7c is based on 
1H NMR spectroscopic studies, where the progression of thermolysis was directly 
monitored in THF-d8 (Figure 2.4, B). As the thermolysis proceeds, the majority of the 
1,2-DAP was observed to form 7c. A slow degradation of 7c was observed by TLC, upon 
its formation, when sitting at room temperature. Thus, the messy baseline that is visible 
in the figure is assumed to be a result of the slight degradation of 7c upon continued 
thermolysis. Consequently, the instability of the product is the reason for inconsistent 
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Figure 2.4: 1H NMR reaction monitoring of 1,2-DAP thermolysis in d8-THF A) Aromatic 
protons of 7c thermolysis product B) Sample NMR run showing two main species in 
solution, 7c and 1,2-DAP, during thermolysis C) Aromatic protons of starting 1,2-DAP
A)
C)
B)
kinetic results when comparing 
1 ,2 -DAP the rmolyses tha t 
monitor formation of product 
against those that track the loss of 
starting material (SM).  
 S e v e r a l t h e r m o l y s i s 
experiments were performed, 
each at different temperatures, 
and samples were extracted from 
the thermolysis vessel at various 
time points. A ratio of SM to standard (ST) was obtained from an integration of peaks in 
the GCMS spectrum after injection with each of these samples (Figure 2.5). A rate 
c o n s t a n t c a n b e t h e n 
de t e rmined f rom each 
thermolysis experiment, 
which can be compiled to 
create an Arrhenius plot 
(Figure 2.6). 
 From the kinetics data 
and resulting Arrhenius plot 
( F i g u r e 2 . 6 ) , t h e 
e x p e r i m e n t a l E A w a s 
determined to be 26.5 kcal/mol, which is within good agreement of the theoretical EA 
value of 26.6 kcal/mol (Figure 2.1). This finding is consistent with the occurrence of an 
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Figure 2.5: Thermolysis experiment results from 90 
ºC run 
Figure 2.6: Arrhenius plot from 1,2-DAP thermolyses
aza-BC event upon the thermolysis of 1,2-DAP, where an intermediate cumulene forms 
and subsequently collapses to form a pyridine-cyclopentane carbene containing species. 
 DFT at the (U)B3LYP/6-31G** level 
DFT calculations using  relatively simple, single-determinant levels of theory, including 
Hartree-Fock and early DFT methods, have been found to be insufficient in adequately 
explaining the classic BC phenomena.36  In the past, substantial inconsistencies have been 
found between (U)B3LYP/6-31G** level of theoretical modeling versus experimental 
results.36 This problem is not unique to the BC, which has led to scientists making public 
pleas to stop using these “outdated” methods.37 
 Briefly, the reasoning for the insufficiencies provided by such “cost-effective” 
calculations are that most enediyne BC events involve diradicaloids with NBMOs being 
at near degenerate energy levels. Therefore, nondynamical correlation effects must 
usually be sufficiently accounted for, which is a significant problem for non-
multireference techniques.38 
The notable agreement between theoretical and experimental calculations outlined 
in this chapter indicates that the 1,2-DAP thermolysis event is better explained with 
calculations that sufficiently consider dynamic correlation, i.e. tight electron pairing.39 
Furthermore, this agreement is an indication that the 1,2-DAP’s aza-BC intermediate 
contains less radical character than the classic enediyne BC systems. Further highlighting 
the importance of the ionic route for this modified aza-enediyne. 
It is well known that by substituting a nitrogen into the classic all-carbon 
enediyne core, you can significantly change the direction of a thermolysis event. The 
expansion that lies with the heterocyclic aza-enediynes involves their tendency towards 
the retro-aza Bergman rearrangement, even without the ability to form a stable nitrile 
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product. In summation, there is good evidence that a retro-aza-Bergman event occurs 
upon the thermolysis of the 1,2-dialkynylpyrrole. This rearrangement is characterized by 
the formation and subsequent collapse of a cumulene intermediate, ending with a multi-
cyclic, pyridine-containing carbene species.  
These findings are consistent with the previously studied 1,2-dialkynylimidazole 
series. The lone pair of electrons on the nitrogen that is proximally located to the formed 
diradicaloid is sufficient in contributing a stabilizing resonance effect. This stabilization 
lowers the energy barrier for the retro-Bergman rearrangement, still making it a more 
favorable occurrence relative to H-atom abstraction. Thus, the elusive diradical remains 
untrapped. 
Experimental  
 General. Unless otherwise noted, all commercially available reagents were used 
without additional purification. THF was dried prior to use by distilling from Naº/
benzophenone. Solvent dried over sieves were left at a minimum of 24 h over 3Å 
activated sieves. All reactions were performed under an atmosphere of argon in oven-
dried glassware with magnetic stirring. Reactions were followed by TLC. 1H NMR 
spectra were recorded at 400 MHz and are reported in ppm. The syntheses of 1H-
pyrrole-2-carbaldehyde40 and (bromoethynyl)triisopropylsilane41 were performed 
according to known literature procedure. Room temperature is assumed to be 20-25 ºC. 
Temperatures for reactions run at -78 ºC and 0 ºC were achieved using dry ice/acetone 
and ice water baths, respectively.  
Procedure for the synthesis of 1-((triisopropylsilyl)ethynyl)-1H-pyrrole-2-
carbaldehyde 6c.34 Toluene (5.7mL, 0.5 M), distilled from Naº/benzophenone, was added 
to a pressure tube containing K2CO3 (470 mg, 3.4mmol), CuSO4(H2O)5 (142 mg, 0.57 
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mmol), 1,10-phenanthroline (103 mg, 0.57 mmol), and 1H-pyrrole-2-carbaldehyde40 (273 
mg, 2.9 mmol). Upon addition of (bromoethynyl)triisopropylsilane41 (898 mg, 3.4 mmol) 
to the mixture, the tube was sealed and placed in an oil bath and heated to 140 ºC 
overnight. The mixture was then cooled and the solvent evaporated. The crude mixture 
was subjected to SiO2 flash chromatography (0-5% EthOAc-hexanes) to yield 6c as a 
colorless oil (770 mg, 97%). 1H NMR (400 MHz, CDCl3) δ 9.85 (s, 1H), 7.12 (dd, J = 
2.7, 1.5 Hz, 1H), 6.99 (dd, J = 4.0, 1.5 Hz, 1H), 6.31-6.29 (m, 1H), 1.13-1.11 (m, 21H); 
13C{1H} NMR (400 MHz, CDCl3) δ 178.82, 134.62, 132.09, 118.78, 111.84, 92.78, 70.36, 
18.68, 11.35; HRMS (ESI) m/z calc’d for C16H25NOSi (M+Na+):298.15980, found 
298.16050.  
M o d i f i e d p ro c e d u re f o r t h e s y n t h e s e s o f d i m e t h y l ( 2 - o x o - 2 -
phenylethyl)phosphonate 7a and subsequent 2-ethynyl-1-((triisopropylsilyl)ethynyl)-1H-
pyrrole 7b.35,42 At -78 ºC, n-BuLi [1.6M] (23.3 mL, 37.2 mmol) was added dropwise to a 
solution of dimethyl methylphosphonate (3.3 mL, 31 mmol) in THF (39 mL, 0.8 M) and 
was allowed to stir for 30 min. Methyl benzoate (4.3 mL, 34.1 mmol) was then slowly 
added and the reaction allowed to stir another 30 min at -78 ºC, followed by an additional 
hour of stirring at 0 ºC. An aqueous solution of hydrogen chloride (40 mL, 1M) was then 
added to the solution at 0 ºC, and allowed to sit overnight as it warmed to room 
temperature. The reaction was extracted into CHCl3 (6 x 40 mL) and the organics were 
collected and dried over anhydrous Na2SO4 and evaporated to yield dimethyl (2-oxo-2-
phenylethyl)phosphonate as a colorless oil (85% yield).42 A portion of the phosphonate 
(685 mg, 3 mmol) was then added to dried CH3CN (5 mL, 0.6 M) at 0 ºC, to which oven-
dried K2CO3 (1.33 g, 9.6 mmol) and then tosyl azide (0.5 mL, 3.3 mmol) were added. 
The reaction was stirred at room temperature for 3 h. 1-((triisopropylsilyl)ethynyl)-1H-
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pyrrole-2-carbaldehyde  (6c, 513 mg, 1.9 mmol) was dissolved in dried methanol (10 mL, 
0.2 M) then added to the reaction vessel,35 and the resulting solution was allowed to stir 
at room temperature overnight. Water was then added to the resultant mixture (10 mL) 
and extracted into CHCl3 (6 x 10 mL). The organics were collected and dried over 
anhydrous NaSO4, filtered and concentrated under reduced pressure. After SiO2 flash 
chromatography (100% hexanes), 7b was isolated as a yellow oil (256 mg, 50%). 1H 
NMR (400 MHz, CDCl3) δ 6.87 (dd, J = 3.0, 1.5 Hz, 1H), 6.45 (dd, J = 3.7, 1.5 Hz, 1H), 
6.10 (dd, J = 3.7, 3.0 Hz 1H), 3.33 (s, 1H), 1.12 (s, 21H); 13C{1H} NMR (400 MHz, 
C4D8O) δ 127.0, 120.2, 117.2, 111.1, 95.8, 84.4, 74.9, 68.7, 19.2, 12.4; HRMS (CI) m/z 
calc’d for C17H25NSi (M+H+): 272.1835, found 272.1830. 
General procedure for the synthesis of 1,2-diethynyl-1H-pyrrole 1,2-DAP. 
Deprotection of 2-ethynyl-1-((triisopropylsilyl)ethynyl)-1H-pyrrole (46 mg, 0.17 mmol) 
7b using tetra-n-butylammonium fluoride (TBAF) (0.2 mL, 0.20 mmol, 1M) in THF (0.9 
mL, 0.2M) at -78 ºC for 10 min afforded near complete conversion to 1,2-DAP, as 
determined by TLC. Due to the volatility of the product, the entire reaction crude 
mixture, including the reaction solvent, underwent SiO2 flash chromatography using dried 
THF as the mobile phase. Fractions were collected on ice and then analyzed for purity by 
TLC, to subsequently be used in the thermolysis experiments. (Note: All steps should be 
performed in a well-ventilated environment. The inhalation of 1,2-DAP leads to 
headaches and should be avoided.) To perform spectral analysis, the deprotection was 
performed and then purified in THF-d8. 1H NMR (400 MHz, C4D8O) δ 6.98 (dd, J = 3.0, 
1.5 Hz, 1H), 6.41 (dd, J = 3.8, 1.5 Hz, 1H), 6.12 (dd, J = 3.7, 3.0 Hz, 1H), 4.43 (s, 1H), 
3.90 (s, 1H); 13C{1H} NMR (400 MHz, C4D8O) δ 127.2, 119.9, 117.3, 111.2, 84.3, 74.8, 
74.6, 59.7; HRMS (CI) m/z calc’d for C8H5N: 115.0422, found 115.0422.  
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P r o c e d u r e f o r t h e s y n t h e s i s o f 3 ' , 4 ' , 5 ' , 6 ' -
tetrahydrospiro[cyclopenta[b]pyridine-5,2'-pyran] 7c. After thermolysis of 1,2-DAP 
(estimated 0.17 mmol starting diyne after deprotection of 7b) was performed at 90 ºC for 
19 h, the THF solvent was evaporated and the crude mixture was subjected to SiO2 flash 
chromatography (25% EthOAc in hexanes) to yield 7c as a yellow oil (8 mg, 25% yield, 
~95% pure). 1H NMR (400 MHz, CDCl3) δ 8.39 (dd, J = 5.2, 1.5 Hz, 1H), 7.71(ddd, J = 
7.4, 1.5, 0.7 Hz, 1H), 7.21 (d, J = 6.0 Hz, 1H), 7.09 (dd, J = 7.5, 5.1 Hz, 1H), 6.88 (dd, J 
= 6.0, 0.7 Hz, 1H), 4.05-3.99 (m, 1H), 3.88-3.81 (m, 1H), 2.09-1.95 (m, 2H), 1.89-1.72 
(m, 3H), 1.61-1.54 (m, 1H); 13C{1H} NMR (400 MHz,CDCl3) δ 162.2, 149.2, 142.0, 
141.8, 133.7, 129.6, 120.7, 84.0, 65.8, 32.3, 25.8, 21.8; HRMS (CI) m/z calc’d for 
C12H13NO: 187.0997, found 187.0992.  
General procedure for kinetics experiments. Quantitative analysis was 
performed using a low resolution, Agilent Technologies 5977E Single Quadrupole GC/
MS. Column specs: 30m RXi-5ms (Restek), 0.25 mm i.d., 0.025 µm phase thickness. The 
initial oven temperature was set to 40 ºC. A default method was used and is as follows: 
hold for 1 min at 40 ºC followed by an increase in temperature at a rate of 20 ºC/min until 
320 ºC is reached, then hold for 3 min. Injector temperature was set to 280 ºC with a 
splitless injection hold time of 1 min. Helium flow rate was set to 1.2 mL/min. The data 
was processed using Agilent MassHunter Qualitative Analysis.  
Preparation of stock solution. After purification of the 1,2-DAP (~1.04 mmol), 
the solution of was further diluted with dried THF to yield an approximate final 
concentration of 0.005 M (208 mL). The solution was kept at 0 ºC in order to minimize 
evaporation of 1,2-DAP. The internal standard, 1,10-phenanthroline (42.6 mg, 0.24 
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mmol), was then added to this solution. The stock solution lasts a few weeks, with 
minimal degradation, when stored in the freezer at -20 °C.  
Individual kinetics experiments. For each experiment, 6 mL of stock solution was 
added to an oven-dried, Ar-flushed vial and then sealed airtight. The vial is placed in an 
oil bath that has been set to a specific temperature. At various, pre-determined time-
points, the vial is placed in a 0 ºC icebath, thereby attenuating the thermolysis. Once 
cooled, the vial is opened under a stream of Ar and 0.45 mL is extracted and placed in a 
chilled, Ar-flushed MS vial. This sample is then placed in the freezer until all of the 
samples from that temperature run has been collected.  
GCMS analysis. All samples from each temperature set were run back-to-back on 
the GCMS in order to obtain uniform data points. Samples were kept in the freezer at -20 
°C  until the moment of injection to get an accurate quantitative analysis on the 
disappearance of 1,2-DAP.  It  was  observed  that  the  cyclization  readily  occurred  at 
temperatures as low as 50 °C. 
 Conclusion and future directions  
By better establishing the versatility and applicability of the Bergman rearrangement of 
various aza-enediynes, the potential utility of this phenomena becomes more apparent. 
With heterocyclic aza-enediynes, the unique synthetic possibilities stem from the carbene 
species generated from a cumulene intermediate. A new rearrangement cascade was 
observed, which followed a familiar pattern: rearomatization to form a six-membered 
ring from a five-membered ring. The generality has further implications for future 
synthetic design. Not only does this allow a new way of creating interesting multi-cyclic 
molecules, but they can be rationally designed with simple level theory DFT calculations.  
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 In the future, further elaborating on the effects of the pyrrole ene-core by adding 
new groups off of the 2-ethynyl arm, thereby possibly exaggerating the unique electronic 
effects of the pyrrole ene-core, could provide for an additional level of control. This 
substitution would have the benefit of allowing for easier purification and subsequent 
experimentation by making the volatile 1,2-DAP heavier and less hazardous to use. 
Another possible level of control could be provided by performing the thermolysis in 
different kinds of solvents. If the diradicaloid intermediate could be further stabilized, the 
trapping of either a diradical or a zwitterion intermediate may be seen. Additionally, it 
may be interesting to address whether or not pH is a major factor in affecting the energy 
of formation and lifetime of the diradicaloid intermediate.  
!  20
CHAPTER 3: ATTEMPT TO EXPAND AZA-BERGMAN 
THERMOLYSIS: 1,5-DIALKYNYLPYRAZOLE 
In moving towards a better understanding of how nitrogen containing 
heterocycles on an ene-core behave in the aza-BC, the next step was to thermolyze a 1,5-
dialkynylpyrazole (1,5-DAPz).  
 Synthesis 
Since the 1,2-DAI was found to optimally undergo a BC when containing a 
methoxymethyl arm,30 the main focus of this chapter is on the analogous 1,5-DAPz 
(Scheme 3.1, 8d).  Additionally, by extending the arm, there was the potential for 
intramolecular trapping events.  
 Unlike the difficulty encountered in synthesis of the 1,2-DAP, the synthesis of 8d 
was straightforward. An N-alkynylation43 on the starting pyrazole was followed by an 
iodination and subsequent Sonogashira to form the protected diyne. The added 
methoxymethyl arm would allow for an increased molecular weight with the intent of 
enabling an easier purification. 
 Thermolyses 
Although an easier purification was achieved, the thermolysis ended up yielding more 
convoluted results. No clear aza-BC, compared to the 1,2-DAP, was observed. The 
majority of thermolyses products ended up being dimers (Scheme 3.2). The few addition 
products that were obtained, were predominately observed upon performing the 
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Scheme 3.1
thermolysis in 1,4-dioxane. These products, however, were occasionally complicated to 
decipher and inconsistent in their formation. At least another two addition products were 
formed in dioxane thermolysis experiments, however those could not fully be interpreted 
using the results of MS and NOESY experiments. All vaguely described products, i.e. 
“dimer” or “addition product,” do not have full characterization; they were identified, 
unless stated otherwise, by LCMS and 1H NMR analysis (see Appendix). 
 Possibilities 
The addition product (9b) could be the result of the formation of a zwitterion or 
nucleophilic attack induced cyclization, as was mentioned previously with the 1,2-DAI 
(Figure 1.9). Another possibility towards the formation of addition products could be an 
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Scheme 3.2: Results from several thermolses of a 1,5-DAPz
*Stereochemistry not defined
alternate mode of dioxane radical production from oxygen that may be present in the 
thermolysis experiment vessel. The dioxane radical could have resulted from H-atom 
abstraction, precluding any aza-BC. Similar dioxane H-atom abstractions have been 
shown to occur upon undergoing thermolysis,  likewise resulting in 1,4-dioxane addition 
on to alkynes.44 Therefore, although sparging with Ar was performed before each 
thermolysis experiment, the possibility exists that it was not fully deoxygenated or that 
the air-tight seal had failed.  
Lastly, the aza-BC may have occurred to produce the addition products. An 
explanation for the formation of vinylic products, in experiments where they formed in a 
mixture with cyclized addition products, could be due of H-atom abstraction of solvent 
molecules from the diradicaloid intermediate, forming a radical solvent molecule that 
proceeds to react with starting diyne (Scheme 3.3).45 
Experimental 
Synthesis of 1-((triisopropylsilyl)ethynyl)-1H-pyrazole (8a) Pyrazole (436 mg, 6.4 
mmol) was added to an Ar-flushed pressure tube containing activated sieves (720 mg), 
oven-dried Cs2CO3 (4 g, 12.8 mmol), and CuI (61 mg, 0.32 mmol). Molecular sieve-dried 
dioxane was added (5.2 mL, 1.3 M) and the resulting mixture was sparged with Ar for 30 
min. After sparging, 2-acetylcyclohexanone (AcC) (0.02 mL, 0.128 mmol) and bromo-
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Scheme 3.3: A possible explanation for observed vinylic products
(triisopropylsilyl)-acetylene (1.6 g, 6.1 mmol) were added and the mixture was heated to 
50 °C for 14 h, then 80 °C for 24 h. The reaction was cooled to room temperature, filtered 
and diluted with EthOAc (20 mL), and extracted with aqueous NH4Cl saturated solution 
(20 mL). The isolated aqueous phase was further extracted with EthOAc (3 x 20 mL) and 
the combined organic layers were dried over Na2SO4. Solvent was evaporated off under 
reduced pressure. The residue was purified by flash chromatography to yield 8a as a 
colorless oil (675 mg, 45%). 1H NMR (400 MHz, CDCl3) δ 7.68 (dd, J = 2.6, 0.6 ,1H), 
7.63-7.62 (m, 1H), 6.30 (dd, J = 2.6, 1.9 Hz, 1H), 1.13-1.12 (m, 21H); 13C{1H} NMR 
(400 MHz, CDCl3) δ 142.36, 134.59, 106.92, 106.88, 94.98, 69.43, 18.70, 11.34; HRMS 
(ESI) m/z calcd for C14H24N2Si (M+H+): 249.17820, found 249.17860.  
Synthesis of 5-iodo-1-((triisopropylsilyl)ethynyl)-1H-pyrazole (8b) A solution of 
1-((triisopropylsilyl)ethynyl)-1H-pyrazole (1.9 g, 7.7 mmol) in THF (60 mL, 0.13 M) 
was cooled to -78 °C. The addition of n-BuLi (5.8 mL, 1.6 M) occurred in a dropwise 
manner, and the solution was stirred for 30 min. Elemental iodine (2.4 g, 9.2 mmol) was 
added at -78 °C, and the mixture stirred for another 30 min at this temperature. Workup 
with Na2S2O3 and extraction into CH2Cl2, recrystallization in ethanol yielded 8b as a 
white solid (410 mg, 14%). 1H NMR (400 MHz, CDCl3) δ 7.56 (d, J = 1.9, 1H), 6.47 (d, J 
= 1.9, 1H), 1.17-1.15 (m, 21H); 13C{1H} NMR (400 MHz, CDCl3) δ 144.35, 116.53, 
93.63, 87.78, 73.95, 18.78, 11.38. 
Synthesis of 5-(3-methoxyprop-1-yn-1-yl)-1-((triisopropylsilyl)ethynyl)-1H-
pyrazole (8c) and 1-ethynyl-5-(3-methoxyprop-1-yn-1-yl)-1-1H-pyrazole (8d) 5-Iodo-1-
((triisopropylsilyl)ethynyl)-1H-pyrazole (1.3 g, 3.5 mmol) was added to a flask charged 
with CuI (13.3 mg, 0.07 mmol) and Pd(PPh3)4 (46.2 mg, 0.04 mmol). Distilled 
triethylamine (30 mL, 0.1 M) dried over CaH2 was added and the mixture was sparged for 
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30 min. Once 3-methoxyprop-1-yne (269.85 mg, 0.33 mL, 3.85 mmol) was added, the 
flask was sealed with a glass stopper and heated to 50 °C for 14 h. Care was taken to 
ensure an adequate amount of headspace. NH4Cl solution (aqueous) was added and 
extraction with DCM was performed, and 8c was isolated using flash chromatography 
(1.09 g, 98%). HRMS (ESI) m/z calcd for C18H28N2OSi (M+H+): 317.20440, found 
317.20470. Deprotection was then performed by adding some of the protected diyne (250 
mg, 0.79 mmol) to a flask containing THF (4 mL, 0.2 M), dropping the temperature to 
-78 °C, and then adding TBAF (0.95 mmol, 0.95 mL, 1M) to afford 8d (66 mg, 52%) 1H 
NMR (400 MHz, CDCl3) δ 7.60 (d, J = 1.9, 1H), 6.45 (d, J = 1.9, 1H), 4.38 (s, 2H), 3.47 
(s, 3H), 3.28 (s, 1H); HRMS (CI) m/z calcd for C9H8N2O: 160.0637, found 160.0634. 
Synthesis of 1-(2-(1,4-dioxan-2-yl)vinyl)-5-(3-methoxyprop-1-yn-1-yl)-1H-
pyrazole (9a) A solution of 8d (0.88 mmol, 140 mg) was diluted in dioxane (40 mL, 0.02 
M), sparged with Ar and heated to 100 °C for 7 d. Solvent was evaporated and the crude 
was subjected to SiO2 flash chromatography (5% MeOH in DCM) to yield many species, but 
predominately 9a (5 mg, 0.02 mmol, 2%). 1H NMR (400 MHz, CDCl3) δ 7.56-7.55 (m, 1H), 
7.35-7.31 (m, 1H), 6.49 (d, J = 1.9 Hz, 1H), 6.24 (dd, J = 13.9, 6.06 Hz, 1H), 4.38 (s, 
2H), 4.31-4.25 (m, 1H), 3.90-3.78 (m, ~3-4 H), 3.78-3.71 (m, ~1-2 H), 3.70-3.61 (m, 
~1-2H), 3.47-3.41 (m, 3H). 
Synthesis of 7-chloro-5-(methoxymethyl)pyrazolo[1,5-a]pyridine (9b) A solution 
of 8d (0.5 mmol, 80 mg) was diluted in CH2Cl2 (5 mL, 0.1 M), sparged with Ar and 
heated to 100 °C for 67 h. The CH2Cl2 was evaporated and the crude was subjected to 
SiO2 flash chromatography (20% EthOAc in hexanes) to yield 9b (26 mg, 0.13 mmol, 26%) as a 
yellow oil. 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = 2.3 Hz, 1H), 7.45-7.44 (m, 1H), 
6.90 (dd, J = 1.4, 0.3 Hz, 1H), 6.60 (d, J = 2.3 Hz, 1H), 4.45 (m, 2H), 3.42 (s, 3H). 
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